|
Re: Going on 5 months since database lock....
|
8
|
Resverlogix Corp.
|
Feb 13, 2020 12:50PM
|
|
Re: Lilly to Discontinue Development of Evacetrapib
|
8
|
Resverlogix Corp.
|
Nov 17, 2015 10:48AM
|
|
Re: New RVX Publication in Atherosclerosis
|
8
|
Resverlogix Corp.
|
Jan 24, 2016 04:04PM
|
|
Re: Market Cap Context
|
8
|
Resverlogix Corp.
|
Jul 05, 2019 10:54AM
|
|
Re: Comments on the AGM
|
8
|
Resverlogix Corp.
|
Nov 08, 2019 07:14PM
|
|
Re: Now published: Rationale, design, and baseline characteristics of the BETonMACE trial
|
8
|
Resverlogix Corp.
|
Sep 16, 2019 02:21PM
|
|
What's happening in the 2 1/2 weeks until the AGM
|
8
|
Resverlogix Corp.
|
Sep 11, 2015 12:00PM
|
|
Re: Resverlogix Announces Seventh Positive Recommendation From The Data Safety Monitoring Board For Phase 3 Study of Apabetalone
|
8
|
Resverlogix Corp.
|
Aug 07, 2018 12:04PM
|
|
New RVX Blog 9/22/16: RESVERLOGIX’S POSTER PRESENTATION AND EVIDEO FROM THE EASD
|
8
|
Resverlogix Corp.
|
Sep 22, 2016 12:13PM
|
|
A Second Publication Shortlists Resverlogix Clinical Candidate Apabetalone for its Potential COVID-19 Effectiveness Including Reducing Cytokine Storms
|
8
|
Resverlogix Corp.
|
Oct 26, 2020 08:15AM
|
|
Resverlogix presented at Vascular Discovery 2018
|
8
|
Resverlogix Corp.
|
May 17, 2018 03:43PM
|
|
Stonegate Capital Partners Initiates Coverage on Resverlogix
|
8
|
Resverlogix Corp.
|
Nov 05, 2015 04:31PM
|
|
Re: Sneaking Suspicion...
|
8
|
Resverlogix Corp.
|
Feb 05, 2021 06:42AM
|
|
Re: New article from EHJ
|
8
|
Resverlogix Corp.
|
Jan 30, 2018 09:51AM
|
|
Re: What are we expecting to learn from scheduled webcast ? ( first week of March)
|
8
|
Resverlogix Corp.
|
Feb 20, 2016 12:08PM
|
|
Anyone else find it odd......
|
8
|
Resverlogix Corp.
|
Aug 19, 2019 10:47AM
|
|
Re: BET inhibitors and Pulmonary Hypertension
|
8
|
Resverlogix Corp.
|
Aug 01, 2018 02:03PM
|
|
Highlights of Webast
|
8
|
Resverlogix Corp.
|
Oct 13, 2016 02:35PM
|
|
Re: BETonMACE paper just published
|
8
|
Resverlogix Corp.
|
Mar 27, 2020 10:24PM
|
|
Re: Resverlogix’s Apabetalone Demonstrates a Medical First in Patients with Chronic Kidney Disease
|
8
|
Resverlogix Corp.
|
Apr 27, 2021 09:24PM
|
